N Brereton Medical Technologies Partners with Kymanox to Accelerate Development
and Commercialization of FenBlock
Forest, Virginia – March 1, 2024 – N Brereton Medical Technologies, a pioneering
company in health and wellness innovation, is thrilled to announce a strategic
partnership with Kymanox, a leading life science solutions partner headquartered in
Raleigh, North Carolina.
Kymanox brings to the table a diverse team of experts with a deep understanding of
the life sciences industry. With their unparalleled expertise and track record of success,
Kymanox is well-equipped to support N Brereton Medical Technologies in accelerating
the development, FDA clearance, and commercialization of FenBlock, a
groundbreaking medical device designed to combat the fentanyl and opioid epidemic.
"FenBlock represents a crucial advancement in addiction treatment, and we are
excited to partner with Kymanox to bring this innovative solution to market," said Neil
B. Jackson, Founder and CEO of N Brereton Medical Technologies. "Kymanox's
commitment to excellence and their proven track record make them the ideal partner
to help us navigate the complexities of the regulatory landscape and accelerate the
development and commercialization of FenBlock.”
Kymanox's Global Headquarters, located in Raleigh | Durham | RTP, NC, and
Morrisville, North Carolina, provide the perfect strategic base for collaboration between
the two companies. With access to top-tier talent and state-of-the-art facilities,
Kymanox is well-positioned to support N Brereton Medical Technologies throughout
the development process.
"We are thrilled to partner with N Brereton Medical Technologies to support the
development and commercialization of FenBlock," said Stephen Perry, Founder and
CEO of Kymanox. "At Kymanox, we pride ourselves on our ability to connect the dots
and provide end-to-end solutions that drive success. Together with N Brereton Medical
Technologies, we look forward to making a meaningful impact in the fight against the
fentanyl and opioid epidemic.”
About N Brereton Medical Technologies:
N Brereton Medical Technologies is a leading innovator in health and wellness,
dedicated to developing groundbreaking solutions to address fentanyl and opioid
healthcare challenges. With a focus on empowering patients and transforming lives, N
Brereton Medical Technologies is committed to driving positive change in the
healthcare industry.
About Kymanox:
Kymanox is a premier life science solutions partner, offering a comprehensive suite of
services to support the development, regulatory approval, and commercialization of
pharmaceuticals, biologics, medical devices, and combination products. With a team
of seasoned experts and a proven track record of success, Kymanox is trusted by
leading companies in the life sciences industry.
For more information about N Brereton Medical Technologies, please visit
For more information about Kymanox, please visit www.kymanox.com.
Contact:
Neil B. Jackson
Founder and CEO
N Brereton Medical Technologies
434-509-2999
N Brereton Medical Technologies LLC
Copyright © 2023 N Brereton Medical Technologies LLC - All Rights Reserved.
Website by 828 Marketing
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.